Epimune’s goal is to revolutionize diagnosis and monitoring of patients with disorders of the immune system.
Using epigenetics, Epimune develops & commercializes molecular diagnostic tests for immune cell quantification from a drop of blood.
24 Jul 2024
Epimune presents its novel CD4+ T-helper cell quantification test using dried blood at AIDS 2024.
For a Spanish version of this video please click here!